1Michael R, Zile MR, Dirk L, et al. New concepts in diastolic dysfunction and diastolic heart failure: Part I : diagnosis, prognosis, and measurements of diastolic: function[J]. Circulation, 2002,105( 11 ) : 1387 - 1393.
2Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation, 2002,105:1387-1393.
3European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J, 1998, 19:990-1003.
4Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation, 2000,101:2118-2121.
5Zile MR, Gassch WH, Carroll JD,et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation, 2001, 104:779-782.
6Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation, 2002, 105:1503-1508.
8Yamamoto K, Masuyama T, Sakata Y,et al. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart. J Hypertens, 2002, 20:753-761.
9Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol, 1999, 33:1948-1955.
10Kitzman DW, Gardin JM ,Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol, 2001,87:413-419.
2Hayley BD, Burwash IG. Heart failure with normal left ven- tricular ejection fraction: role of echocardiography [J]. Curr Opin Cardiol, 2012, 27 (2): 169-180.
3Mcmurray JJ, Adamopoulous S, Anker SD, etal. ESC guidelines for the diagnosis and treatment of acute? and? chronic? heart fail- ure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Fail- ure Association (HFA) of the ESC [J]. Eur J Heart Fail, 2012, 14 (8): 803-869.
4Van Bilsen M, Smeets PJ, Gilde A J, eta1. Metabolic remodeling of the failing heart: the cardiac burn-out syndrome [J]. Card- iovasc Res, 2004, 61 (2): 218-226.
6Feng NC, Satoh H, Urushida T et M. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury [J]. J CardiovascPharmacol, 2006, 47 (2): 263-270.
7Tamariz L, Harzand A, Palacio A, et al. Uric acid as a predictor of all- cause mortality in heart failure: a meta- analysis [J]. Congest Heart Fail, 2011, 17 (1): 25- 30.
8Funke-Kaiser A, Mann K, Colquhoun D, et al. Midregional proa- drenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study[J]. Int J Cardiol, 2014,172(2) :411-418. DOI: 10. 1016/j. ijcard. 2014.01. 064.
